IP Library Granted Patent US 7,465,577
Granted Patent B2
US 7,465,577 · App. 11/118,008 · Granted Dec 16, 2008

Methods for reducing or eliminating α-mannosidase resistant glycans for the production of glycoproteins

Assignee: GlycoFi, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,465,577
App. No.
11/118,008
Granted
Dec 16, 2008
Kind
B2
Abstract

The present invention provides methods to reduce or eliminate α-mannosidase resistant glycans on glycoproteins in yeast. The reduction or elimination of α-mannosidase resistant glycans on glycoproteins results from the disruption of the newly isolated P. pastoris AMR2 gene encoding β1,2-mannosyltransferase. The present invention also discloses novel genes, polypeptides, antibodies, vectors and host cells relating to α-mannosidase resistance on glycans.

Claims (8)

1. A modified Pichia pastoris host cell characterized in that the host cell has been modified to reduce expression of a functional gene product of a nucleic acid sequence encoding a polypeptide having the amino acid sequence set forth in SEQ ID NO:12.

2. The modified host cell of claim 1 wherein said modified host cell comprises a disruption or deletion in the nucleic acid sequence encoding a polypeptide having the amino acid sequence set forth in SEQ ID NO:12.

3. The host cell of claim 1 , wherein the host cell further comprises deletion of a functional gene product encoding an alpha-1,6-mannosyltransferase activity.

4. The host cell of claim 1 , wherein the host cell further comprises deletion of a functional gene product encoding mannosylphosphate transferase activity.

5. A modified Pichia pastoris host cell characterized in that the host cell has been modified to reduce expression of a β-mannosyltransferase activity.

6. The modified host cell of claim 5 wherein said modified host cell comprises a disruption or deletion in the nucleic acid sequence encoding the β-mannosyltransferase activity.

7. The host cell of claim 5 , wherein the host cell further comprises deletion of a functional gene product encoding an alpha-1,6-mannosyltransferase activity.

8. The host cell of claim 5 , wherein the host cell further comprises deletion of a functional gene product encoding mannosylphosphate transferase activity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2006
From: BOBROWICZ, PIOTR
To: GLYCOFI, INC.
Reel/Frame 017873/0030 →
Continuity (2)
Provisional Application 6062018600 · Oct 18, 2004
Related Publication 20060211085A1 · Sep 21, 2006